Spravato Nasal Spray - Search News

FDA Approves ‘Spravato’ Nasal Spray

Hosted on MSN · 8h

FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult population.

UPI News on MSN · 1d

FDA approves Spravato, first monotherapy nasal spray to treat depression

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato was approved to treat a major depressive disorder,

Popular Science · 1d

FDA approves first-of-its-kind nasal spray for severe depression

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD, and similar psychiatric conditions.

21hon MSN

Nasal spray approved to help treat depression

The U.S. Food and Drug Administration has approved a nasal spray that is known to help treat depression.

Inquirer on MSN3d

Controlled drug Ketamine a lifeline for patients with severe depression in Singapore

SINGAPORE (The Straits Times/ANN): Ketamine, the controlled drug best known as a horse tranquilliser or party supplement, has ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results